The above chart presents the market trend analysis for alcapharm b.v. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 13 transactions, with a transaction quantity of 48620 and a transaction weight of 0.
YearTransactionsQuantityWeight
Bill of lading data
<
1/15
>
Trade date
2025/09/15
B/L No.
107527859351
Supplier
alcapharm b.v.
Buyers
công ty cp dược phẩm imexpharm
Product description
Nguyên liệu dùng sản xuất tân dược: CEFDINIR (TC: USP 2025). (SĐK: VD-27894-17) Hàng mới 100%. Lô: CDRC250011. NSX: 07/2025, HD: 06/2028. NSX: COVALENT LABORATORIES PRIVATE LIMITED - INDIA
Expand
Product description
Nguyên liệu dùng sản xuất tân dược: CEFDINIR USP 2025. (SDK: VD-27894-17) Hàng mới 100%. Lô: CDRM250029. NSX: 06/2025, HD: 05/2028. NSX: COVALENT LABORATORIES PRIVATE LIMITED - INDIA
Expand
Trade date
2025/07/25
B/L No.
107383166000
Supplier
alcapharm b.v.
Buyers
công ty cp xuất nhập khẩu y tế domesco
Product description
Nguyên liệu dùng sản xuất thuốc: AMOXICILLIN TRIHYDRATE BP2025, Lot: M487920; M487930, SX: 05,06/2025; HD:04, 05/2030 ; NSX: Centrient Pharmaceuticals India Pvt.,Ltd-India
Expand
Trade date
2025/07/25
B/L No.
107382900920
Supplier
alcapharm b.v.
Buyers
công ty cp xuất nhập khẩu y tế domesco
Product description
Nguyên liệu dùng sản xuất thuốc: AMOXICILLIN TRIHYDRATE BP2025, Lot: M487930; SX: 06/2025; HD: 05/2030 ; NSX: Centrient Pharmaceuticals India Pvt.,Ltd-India
Expand
Product description
Nguyên liệu dùng sản xuất tân dược: CEFDINIR USP 2024 (cỡ hạt < 180 micron) (VD-27894-17) Hàng mới 100%. Lô: CDRC250004. NSX: 03/2025, HD: 02/2028. NSX: COVALENT LABORATORIES PRIVATE LIMITED - INDIA
Expand
Product description
Nguyên liệu dùng sản xuất thuốc: AMOXICILLIN TRIHYDRATE BP2024, Lot: M200343, M200344, M200345, M200346; 12/2024; HD:11/2029 ; NSX: Centrient Pharmaceuticals India Pvt.,Ltd-India
Expand
Trade date
2024/12/23
B/L No.
106824923000
Supplier
alcapharm b.v.
Buyers
công ty cp dược phẩm imexpharm
Product description
Nguyên liệu dùng sản xuất tân dược: Cefixime Trihydrate USP44. SDK: 893110146223, Lô: CFEC240801. NSX: 12/2024. HD: 11/2027. NSX: Covalent Laboratories Private Limited, India. Hàng mới 100%.
Expand
Trade date
2024/10/22
B/L No.
106664695800
Supplier
alcapharm b.v.
Buyers
công ty cp dược phẩm imexpharm
Product description
Nguyên liệu dùng sản xuất tân dược: CEFIXIME TRIHYDRATE USP44 (SĐK: 893110146223). Lô: CFEC240670. NSX: 10/2024, HD: 09/2027. NSX: COVALENT LABORATORIES PRIVATE LIMITED - INDIA. Hàng mới 100%.
Expand
alcapharm b.v. is netherlands Buyer&Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2025-09-15, the company has completed 752 international trades,
with its main trading regions covering vietnam,turkey,indonesia etc.
The core products include HS29419000,HS29411019,HS294110000011 etc,
often transported via qingdao,port rotterdam, port nhava sheva in etc,
and its main trading partners are atabay kimya sanayive tic.a.ş.,cong ty cp duoc pham imexpharm,imexpharm.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on alcapharm b.v. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.